Cellectar Awarded $2M Grant
Cellectar Biosciences has been awarded $1.98 million in additional grant funding by the National Institute of Health’s National Cancer Institute (NCI), the company announced today. According to a release, the…
Cellectar Biosciences has been awarded $1.98 million in additional grant funding by the National Institute of Health’s National Cancer Institute (NCI), the company announced today. According to a release, the…
SHINE Technologies and Radiopharm Theranostics signed a clinical supply agreement, in which SHINE will supply Radiopharm with isotope non-carrier-added lutetium-177 (Lu-177), the company announced recently. “One way or another, nearly…
Elephas Biosciences Corporation, a biotech company that developed an oncology diagnostics platform to predict response to immunotherapy, has raised $41.5 million in a Series B funding round, the company announced…
SHINE Technologies named Tom D’Orazio as the CEO of Phoenix, the company announced recently. According to a release, D’Orazio has more than two decades of experience in sales leadership roles…
Immuto Scientific has been awarded a $2.5 million Phase II SBIR grant from the National Institutes of Health (NIH), the company announced recently. According to a release, the grant will…
SHINE Technologies has submitted a Drug Master File (DMF) with the U.S. Food and Drug Administration for non-carrier-added lutetium-177 (Lu-177) chloride, the company announced recently. According to a release, the…
BrightStar Wisconsin Foundation announced recently that it has invested in SpayVac, an animal sterilization technology company. “Issues with feral animals have reached crisis level in parts of the world and…
NorthStar Medical Technologies promoted Dr. Frank Scholz as its new President and Chief Operating Officer, the organization announced recently. “I want to congratulate Frank Scholz on this well-deserved promotion to…
SHINE Technologies announced recently that Holli C. Ladhani and Janet S. Wong have joined its board of directors. “We are excited to bring these two highly talented individuals to our…
Promega is launching a post-doctoral research program for life science researchers to explore new ideas for genome engineering technology, the company announced today. AstraZeneca will provide mentoring support in the three-year…